Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 9Colorectal Neoplasms 5Neoplasms 4Prostatic Neoplasms 3Colonic Neoplasms 2Smoking Cessation 1Patient Participation 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Colorectal Cancer Screening 1COVID-19 1Breast Cancer Screening 1Behavior 1

Interventions

Fluorouracil 128Leucovorin 120Oxaliplatin 101Irinotecan 89Bevacizumab 55Cetuximab 44Capecitabine 40Folfox protocol 29Panitumumab 22Colonoscopy 17Chemotherapy, Adjuvant 16Floxuridine 15Early Intervention, Educational 15Erlotinib Hydrochloride 13Surveys and Questionnaires 11IFL protocol 11Counseling 11Celecoxib 11Immunohistochemistry 10Gemcitabine 10Psychiatric Rehabilitation 9Methods 8Magnetic Resonance Spectroscopy 8Gene Expression Profiling 8Exercise 8Dexamethasone 8sargramostim 7Sorafenib 7Radiotherapy 7Nivolumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Colonic Neoplasms × Decision Support Techniques × Clear all
NCT04548531 2023-02-22

Engaging Patients in Colon Cancer Screening Decisions During COVID-19

Massachusetts General Hospital

Phase NA Completed
800 enrolled 13 charts
Gastrointestinal

COVID-19, Colonic Neoplasms

NCT02377232 2017-06-26

CRCSreening

University of Colorado, Denver

Phase NA Completed
424 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡